Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Abrupt deterioration and pulmonary embolism in COVID-19: a case report

Manish Motwani
Download PDF
DOI: https://doi.org/10.7861/clinmed.2020-0307
Clin Med July 2020
Manish Motwani
AManchester Heart Centre, Manchester, UK and University of Manchester, Manchester, UK
Roles: consultant cardiologist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mani.motwani@mft.nhs.uk
  • Article
  • Figures & Data
  • Info & Metrics
Loading

ABSTRACT

A case is presented highlighting pulmonary embolism as an important complication of COVID-19 and the abruptness with which deterioration and widespread pulmonary infiltrates can develop even after relatively normal initial investigations, illustrating the importance of follow-up. The role of computed tomography in COVID-19 is also discussed.

KEYWORDS
  • COVID-19
  • pulmonary embolism
  • pneumonia
  • deterioration

Case report

A 52-year-old man attended the medical assessment unit with a 5-day history of dry cough, fever, and dyspnea. He had no pre-existing medical conditions. Investigations showed a normal full blood count, normal renal and liver biochemistry, normal troponin, normal clotting profile, and only mildly raised C-reactive protein (CRP). Arterial blood gas sampling including oxygenation was within normal range. A CXR and electrocardiograph were also normal. Same-day PCR nasopharyngeal swab detected severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) RNA, confirming coronavirus disease-19 (COVID-19). As his symptoms were relatively mild and there were no high-risk comorbidities, he was discharged home with virtual clinic follow-up (daily telephone assessments).

Three days later he was significantly more breathless and was advised to re-attend – his oxygen saturation was now 83% on air. Computed tomography (CT) pulmonary angiography showed widespread bilateral ground-glass opacities consistent with extensive COVID-19 pneumonitis and substantial bilateral subsegmental pulmonary emboli (Fig 1; see also video at https://youtu.be/frh28BOkhtg). Blood tests now showed the typical COVID-19 profile with mild lymphopenia, mildly raised alanine aminotransferase and lactate dehydrogenase, modestly raised CRP, normal procalcitonin, raised ferritin and substantially raised D-dimer. He was treated with supportive care, high-flow oxygen, and direct oral anticoagulant; fortunately, he did not require mechanical ventilation or intensive care unit management. After 10 days he had recovered sufficiently to be discharged home.

Fig 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 1.

Chest computed tomography pulmonary angiography and three-dimensional visualisation. a) Lung windowing shows bilateral peripheral ground-glass opacities consistent with COVID-19. b) Angiographic windowing shows bilateral subsegmental pulmonary emboli (arrows). Three-dimensional volume-rendering of thickened coronal slab (c; abnormal lung is green; pulmonary embolus also visualised, arrow) and of whole-data segmented lung parenchyma (d; abnormal lung is purple) helps visually demonstrate the widespread inflammatory burden.

Discussion

This case highlights the abruptness with which deterioration and widespread pulmonary infiltrates can develop in COVID-19 even after relatively normal initial investigations. It also highlights pulmonary embolic disease as an important complication, reported in up to 33% of cases.1,2 it is uncertain if the etiology is pulmonary thrombosis, thrombo-embolism or part of cytokine-storm-driven disseminated intravascular coagulation.2 Further studies are required to understand the pathophysiology behind this complication of COVID-19 and guide universally agreed anticoagulation policies.

Regarding the role of CT in COVID-19, professional societies have cautioned against its routine use as a first-line diagnostic test – because although highly sensitive, the CT features of COVID-19 pneumonia are not specific and also tend to peak later (day 6–11).3 Importantly, indiscriminate use of CT also places healthcare workers (eg technologists) at risk of exposure. Accordingly, most suspected COVID-19 patients are diagnosed on the basis of clinical assessment, CXR and blood tests while awaiting PCR results.

Nonetheless, with recognition of poor PCR sensitivity, many centres adopt the pragmatic approach of using CT in cases with the combination of high clinical suspicion, normal or indeterminate CXR, and negative PCR result, and in patients with marked deterioration in order to exclude occult pulmonary embolism.3 However, as decontamination and patient segregation protocols become more embedded in hospitals, the risk–benefit ratio may ultimately support wider diagnostic use. New CT technology and advances in post-processing may also support further application. For example, we highlight how simple 3D-volume rendering and semi-automated segmentation can provide a rapid visual map of inflammatory burden and the extent of disease, but this can be taken further: artificial intelligence methods have already been utilised to fully quantify opacity burden (facilitating response to treatment assessments) and distinguish findings in COVID-19 from community-acquired pneumonia or other lung disease. Such tools may prove indispensable in a prolonged pandemic or during a second wave.4

  • © Royal College of Physicians 2020. All rights reserved.

References

  1. ↵
    1. Grillet F
    , Behr J, Calame P, et al. Acute pulmonary embolism associated with COVID-19 pneumonia detected by pulmonary CT angiography. Radiology 2020, in press (doi: 10.1148/radiol.2020201544).
  2. ↵
    1. Poissy J
    , Goutay J, Caplan M, et al. Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence. Circulation 2020, in press (doi: 10.1161/CIRCULATIONAHA.120.047430).
  3. ↵
    1. Tavare AN
    , Braddy A, Brill S, et al. Managing high clinical suspicion COVID-19 in patients with negative RT-PCR: a pragmatic and limited role for thoracic CT. Thorax 2020, in press (doi: 10.1136/thoraxjnl-2020-214916).
  4. ↵
    1. Kundu S
    , Elhalawani H, Gichoya JW, Kahn CE Jr.. How might AI and chest imaging help unravel COVID-19's mysteries? Radiology Artificial Intelligence 2020, in press (doi: 10.1148/ryai.2020200053).
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Abrupt deterioration and pulmonary embolism in COVID-19: a case report
Manish Motwani
Clinical Medicine Jul 2020, 20 (4) e95-e96; DOI: 10.7861/clinmed.2020-0307

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abrupt deterioration and pulmonary embolism in COVID-19: a case report
Manish Motwani
Clinical Medicine Jul 2020, 20 (4) e95-e96; DOI: 10.7861/clinmed.2020-0307
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • ABSTRACT
    • Case report
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Real-world use of the Breathing Pattern Assessment Tool in assessment of breathlessness post-COVID-19
  • Understanding the diagnosis and management of multisystem inflammatory syndrome in adults (MIS-A) in the UK: results of a national Delphi process
  • The clinical course of pneumomediastinum in patients with SARS-CoV-2 before invasive mechanical ventilation
Show more COVID-19 rapid report

Similar Articles

FAQs

  • Difficulty logging in.

There is currently no login required to access the journals. Please go to the home page and simply click on the edition that you wish to read. If you are still unable to access the content you require, please let us know through the 'Contact us' page.

  • Can't find the CME questionnaire.

The read-only self-assessment questionnaire (SAQ) can be found after the CME section in each edition of Clinical Medicine. RCP members and fellows (using their login details for the main RCP website) are able to access the full SAQ with answers and are awarded 2 CPD points upon successful (8/10) completion from:  https://cme.rcplondon.ac.uk

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians